|
|
|
|
|
|
|
Jaguar Animal (JAGX)
|
|
0.155 0.005 (3.33%)
|
05-21 16:00
|
|
Open:
|
0.1487
|
Pre. Close:
|
0.15
|
|
High:
|
0.1698
|
Low:
|
0.145
|
|
Volume:
|
6,476,802
|
Market Cap:
|
27M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
0.17 - 0.171
|
0.171 - 0.172
|
|
Low:
|
0.138 - 0.139
|
0.139 - 0.14
|
|
Close:
|
0.159 - 0.16
|
0.16 - 0.161
|
|
|
|
Technical analysis (as of: 2018-05-21 4:30:40 PM)
|
|
Overall:
|
 
|
|
Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.
|
|
Target:
|
Six months: 7.02 One year: 11.26
|
|
Support:
|
Support1: 0.14 Support2: 0.12
|
|
Resistance:
|
Resistance1:
6.01 Resistance2: 9.64
|
|
Pivot:
|
0.79
|
|
Moving Averages:
|
MA(5): 2.05 MA(20): 0.64
MA(100): 0.26  MA(250): 0.34
|
|
MACD:
|
MACD(12,26):
0.58 Signal(12,26,9): 0.23
|
|
%K %D:
|
%K(14,3): 36.70 %D(3): 34.97
|
|
RSI:
|
RSI(14): 48.13
|
|
52-Week:
|
High: 0.99
Low: 0.105 Change(%): -76.5
|
|
Average Vol(K):
|
3-Month: 870777
10-Days 206503
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.JAGX has closed above bottom band by 43.3%. Bollinger Bands are 3725.8% wider than normal. The large width of the bands suggest high volatility as compared to JAGX's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue.
|
|
|
Headline News
|
|
2018-05-21T22:09:06-04:00
Jaguar Animal Health's (JAGX) CEO Lisa Conte on Company Updates Broker Conference Call - (Transcript)
2018-05-20T12:31:16-04:00
Jaguar Animal Health reports Q1 results
2018-03-13T15:00:00-04:00
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Jaguar Health, Inc.
2018-03-08T14:10:12-05:00
Jaguar Health spikes 140%
2018-03-08T12:38:01-05:00
Midday Gainers / Losers (3/8/2018)
2018-01-22T17:49:07-05:00
Jaguar Health's (JAGX) CEO Lisa Conte on Company Updates Conference Call - Earnings Call Transcript
2018-01-22T16:00:00-05:00
Jaguar Health Provides Updates Regarding Commercial, Educational & Product Development Programs and 2017 Results for Mytesi Since Merger (August-December 2017)
2018-01-18T09:00:00-05:00
Jaguar Health to Host Conference Call Monday, January 22nd at 4:15 p.m. Eastern Time to Provide Updates Regarding Jaguar and Napo Pharmaceuticals Commercial, Educational & Product Development Activities and 2017 Results
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
